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The role of retinoic acid receptors (RARs) in intercellu-
lar regulation of cell growth was assessed by targeting
a dominant-negative RARα mutant (dnRARα) to dif-
ferentiated suprabasal cells of mouse epidermis.
dnRARα lacks transcriptional activation but not DNA-
binding and receptor dimerization functions. Analysis
of transgenic mice revealed that dnRARα dose-depend-
ently impaired induction of basal cell proliferation and
epidermal hyperplasia by all-trans RA (tRA). dnRARα
formed heterodimers with endogenous retinoid X
receptor-α (RXRα) over RA response elements in
competition with remaining endogenous RARγ–RXRα
heterodimers, and dose-dependently impaired retinoid-
dependent gene transcription. To identify genes regu-
lated by retinoid receptors and involved in cell growth
control, we analyzed the retinoid effects on expression
of the epidermal growth factor (EGF) receptor, EGF,
transforming growth factor-α, heparin-binding EGF-
like growth factor (HB-EGF) and amphiregulin genes.
In normal epidermis, tRA rapidly and selectively
induced expression of HB-EGF but not the others.
This induction occurred exclusively in suprabasal cells.
In transgenic epidermis, dnRARα dose-dependently
inhibited tRA induction of suprabasal HB-EGF and
subsequent basal cell hyperproliferation. Together, our
observations suggest that retinoid receptor hetero-
dimers located in differentiated suprabasal cells medi-
ate retinoid induction of HB-EGF, which in turn
stimulates basal cell growth via intercellular signaling.
These events may underlie retinoid action in epidermal
regeneration during wound healing.
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Introduction
Vitamin A and its metabolites (retinoids), such as all-
trans retinoic acid (tRA), are important regulators of
embryo development, cellular activity and tissue homeost-
asis. Their biological effects are mediated by two families
of nuclear hormone receptors, retinoic acid (RAR) and
retinoid X (RXR) receptors, which are ligand-dependent
transcription factors (Kastner et al., 1995; Chambon, 1996;
Minucci and Ozato, 1996; Pfahl and Chytil, 1996; Nagy
et al., 1997; Perlmann and Evans, 1997). Each receptor
family consists of three members, α, β and γ. The
two receptor families display distinct ligand specificities.
Natural retinoids, tRA and its isomer 9-cis RA, are both
recognized by RARs, whereas RXRs interact with 9cRA
but not with tRA. In the form of RAR–RXR or RXR–
RXR dimers, the receptors act through binding to retinoic
acid response elements (RAREs) present in the transcrip-
tional regulatory region (promoter) of target genes. Upon
retinoid binding, the dimers stimulate gene transcription
through interaction with transcriptional co-activators and
thereby confer positive retinoid responsiveness. In the
absence of retinoids or presence of inverse agonists, the
receptor dimers interact with co-repressors and repress
basal transcription of target genes (Chambon, 1996; Klein
et al., 1996; Shibata et al., 1997; Torchia et al., 1998).
The effects of retinoids on cell growth have been
observed in cells cultured in vitro. Surveys of 200 cell
lines have indicated that retinoids either stimulate or
inhibit cell proliferation depending on cell types (Amos
and Lotan, 1990; Rogers, 1997). Notably, retinoids inhibit
proliferation of many fast-growing transformed cell lines,
but promote growth of most primary cells. Studies of
mutant cell lines clearly indicated that RAR and RXR
members are required for retinoids to inhibit proliferation
and promote differentiation of transformed embryonic
cells in vitro (Chiba et al., 1997, and references therein).
Although genes directly associated with cell cycle progres-
sion were found to be up- or down-regulated by retinoids in
cultured cells, the molecular cascades connecting retinoid
receptors to these downstream genes have yet to be
established (Rogers, 1997). On the other hand, in epithelial
tissues in vivo, retinoids such as tRA were also found to
either increase or reduce cell proliferation, depending
upon the physiological state of host tissues (Peck and
Di Giovanna, 1994; Fisher and Voorhees, 1996; Rogers,
1997). For example, treating normal adult human and
mouse skin with pharmacological doses of vitamin A or
tRA increases the proliferation rate of undifferentiated
cells that constitute the basal layer of the epidermis
(basal keratinocytes), leading to an accelerated turnover
of epidermal cells and thickening of the epidermis. How-
ever, in abnormal epithelial tissues such as psoriatic
skin, retinoids mitigate hyperproliferation of abnormal
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epidermal cells. RARγ, RARα, RXRα and RXRβ were
detected in skin, with RARγ and RXRα being the pre-
dominant species (Fisher and Voorhees, 1996). Although
the molecular events underlying retinoid actions in skin
have not been elucidated, retinoid receptor-mediated
signaling within dermal fibroblasts and/or epidermal basal
keratinocytes was suspected to be involved in regulation
of epidermal growth (Peck and Di Giovanna, 1994).
Unexpectedly, a previous study of mouse skin expressing
a dominant-negative RXRα mutant indicated that retinoid
regulation of basal cell proliferation involves RXRs in
differentiated suprabasal cells of the epidermis (suprabasal
keratinocytes) (Feng et al., 1997). Yet, the roles of RARs
and retinoid-targeted genes involved in regulation of basal
cell proliferation have not been elucidated.
Here, we have examined the roles of RARs in retinoid
regulation of cell growth by targeting a dominant-negative
RARα mutant (dnRARα) to the differentiated suprabasal
layers of epidermis. Analysis of transgenic mouse epi-
dermis revealed that dnRARα dose-dependently sup-
pressed tRA induction of the basal cell proliferation
and epidermal thickening. As a result of formation of
transactivation-inactive dnRARα–RXRα heterodimers,
dnRARα dose-dependently impaired the endogenous
RAR–RXR heterodimer-mediated epidermal retinoid
signaling pathway at the level of gene transcription. Most
interestingly, we found that tRA caused an early and
selective induction of one epidermal growth factor (EGF)
family member, heparin-binding EGF-like growth factor
(HB-EGF), which is a paracrine/juxtacrine growth factor
and is expressed exclusively in the differentiated supra-
basal layers of the epidermis. This suprabasal-specific
HB-EGF induction was inhibited in situ by dnRARα. Our
data strongly suggest that RAR–RXR located in suprabasal
cells mediates retinoid induction of HB-EGF, which in
turn stimulates basal cell growth via paracrine/juxtacrine
mechanisms.
Results
Establishment of stable transgenic mouse lines
expressing the dnRARα transgene
Mouse cDNA encoding dnRARα was inserted into a cell
type-specific transgene expression vector (Figure 1A),
which has been constructed previously based on the
bovine keratin-10 gene promoter (Feng et al., 1997). This
promoter has been used to target expression of a variety
of transgenes specifically to differentiated keratinocytes
constituting the suprabasal layers of the epidermis (Feng
et al., 1997, and references therein). dnRARα contains a
C-terminal deletion between amino acids 404 and 462,
which removes ligand-dependent transcription activation
function-2 (AF-2) and a 9cRA-binding site but not the tRA-
binding, receptor dimerization and DNA-binding functions
(Damm et al., 1993; Durand et al., 1994). DNA fragments
containing the K10–dnRARα transgene were isolated and
microinjected into fertilized mouse eggs. Out of 71 pups
born, no stillborn pups were observed, and 13 (18%) were
identified as transgenic mice by PCR genotyping of their
tail DNA (data not shown). At birth, six of 13 transgenic
founders displayed shiny skin. One severely affected
founder had sticky skin and was sacrificed due to the lack
of care from its foster CD-1 mouse (Figure 1B). The shiny
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skin phenotype is similar to that observed with RARγ null
mice (P.Kastner and P.Chambon, unpublished observation)
and transgenic FVB mice in which a human dnRARα
was targeted to epidermis using the human keratin-1 gene
promoter (Imakado et al., 1995). However, similarly to
the RARγ null mice, the shiny skin phenotype dissipated
within 1 week after birth. At adult stages, all transgenic
founders had normal epidermal cellularity and structure.
Six transgenic founders were chosen and back-crossed
with wild-type C57BL/6 mice to establish stable transgenic
lines. The F1 transgenic progeny were analyzed by
Southern blotting analysis of tail DNA. As shown in
Figure 1C, the copy number of the K10-dnRARα transgene
in these six lines varies from three to 58. At birth, the
skin of F1 transgenic pups from lines 4522, 4518 and
4489, but not 4512, 4487 and 4511, was shiny to different
extents, like their founders, with lines 4518 and 4489
being the most prominent, in correlation with levels of
dnRARα expressed (Figure 1D). Northern analysis of
total epidermal mRNA from four of these lines showed
that expression ratios between dnRARα and endogenous
wild-type RARα were between 1.7 and 14 (Figure 1D).
As expected, expression of dnRARα mRNA was restricted
to the epidermis (Figure 1E). Like their founders, the
shiny skin phenotype of the F1 transgenic pups dissipated
within 1 week after birth and, at adult stages, their
epidermal cellularity and structure appeared to be normal.
Suprabasal expression of dnRARα inhibited
induction of epidermal hyperplasia and basal cell
proliferation by tRA in transgenic mouse skin
To investigate the effects of dnRARα expression on
epidermal growth responses to retinoids, we expanded
mouse colonies from three transgenic lines (4522, 4518
and 4489) that express dnRARα at different levels. Back
skin of adult control or transgenic mice was treated with
vehicle or tRA for 4 days, and skin sections were examined
by hematoxylin–eosin staining. As shown in Figure 2A,
tRA significantly increased epidermal cellularity and thick-
ness in control mice. The tRA effects were drastically
inhibited in transgenic mice although epidermal structure
and cellularity appeared to be similar between these mice
without the tRA treatment. The degree of inhibition
(Figure 2B) correlated well with the levels of dnRARα
expressed in these three lines (Figure 1D), with complete
inhibition in line 4489 that expresses the highest level of
dnRARα (Figure 2A). To ascertain whether dnRARα
affected the ability of tRA to induce basal keratinocyte
proliferation, we injected control and transgenic mice
intraperitoneally with 5-bromo-2-deoxyuridine (BrdU).
Proliferating cells that have incorporated BrdU into their
genomic DNA were visualized by staining skin sections
with antibodies specific to BrdU. As shown in Figure 2C,
tRA significantly increased the number of proliferating
basal keratinocytes in control but not transgenic epidermis.
Again, the reduction of tRA-induced cell proliferation
(Figure 2D) was in good correlation with levels of
dnRARα expressed in these transgenic lines (Figure 1D).
These observations suggest that disruption of endogenous
retinoid signaling by dnRARα in differentiated suprabasal
keratinocytes impaired an intercellular signaling path-
way(s) through which retinoids regulate basal cell prolif-
eration.
Intercellular regulation of cell growth by retinoids
dnRARα in transgenic mouse epidermis impaired
endogenous RARγ–RXRα heterodimer-mediated
gene transactivation through formation of
heterodimers with endogenous RXRα
In vitro studies have indicated that dnRARα is capable of
repressing gene transactivation by wild-type RAR–RXR
heterodimers through competitive formation of DNA-
binding-proficient and transactivation-deficient hetero-
dimers, dnRARα–RXRα (Damm et al., 1993; Durand
et al., 1994). By gel mobility supershift analysis, we
examined whether dnRARα in transgenic epidermis was
able to heterodimerize competitively with endogenous
RXRα, the predominant member of the RXR family in
skin (Fisher and Voorhees, 1996). As shown in Figure 3,
in normal mouse epidermis, endogenous RARγ and RXRα
bound to RARE as heterodimers, which were supershifted
by antibodies specific to RARγ, RXR or RXRα, but not
RARα. RARα–RXRα heterodimers were not detected by
gel supershift analysis (Figure 3), probably due to low
levels of RARα expression in normal epidermis
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(Figure 1D; see also Fisher and Voorhees, 1996; Feng
et al., 1997). In transgenic mouse epidermis, dnRARα–
RXRα heterodimers were detected by antibodies specific
to RARα or RXRα, in addition to remaining RARγ–
RXRα heterodimers. These observations indicate that like
dnRXRα (Feng et al., 1997), dnRARα expressed in
transgenic epidermis is capable of interfering with the
function of RARγ–RXRα heterodimers, the predominant
retinoid receptor form in epidermis, through formation of
dnRARα–RXRα heterodimers.
To ascertain whether formation of dnRARα–RXRα
functionally disrupted endogenous RAR–RXR hetero-
dimer-mediated retinoid signaling at the level of gene
transactivation in transgenic epidermis, we analyzed tRA
effects on expression of the cellular retinoic acid-binding
protein II gene (CRABPII), whose promoter harbors two
RAREs (Durand et al., 1992). As shown in Figure 4, both
basal and tRA-induced levels of CRABPII mRNA were
significantly reduced in transgenic epidermis. The degree
of inhibition of the tRA effects (Figure 4) correlated well
with relative levels of dnRARα in the transgenic lines
(Figure 1D). Thus, dnRARα effectively interfered with
endogenous RAR–RXR activity in gene transactivation in
transgenic epidermis.
Early and selective induction of one member of
the EGF family, HB-EGF, by tRA in normal mouse
epidermis
Epidermal growth is regulated by ligands binding to
epidermal growth factor receptor (EGFR) present on basal
keratinocyte membranes (King et al., 1990; Vassar and
Fuchs, 1991). The EGFR ligands including EGF, trans-
forming growth factor-α (TGF-α), HB-EGF and amphi-
regulin are known to stimulate keratinocyte proliferation
Fig. 1. Characterization of the K10–dnRARα transgenic mice.
(A) Structure of the K10–dnRARα transgene. The arrowhead shows
the transcriptional direction in the bovine keratin 10 (BK-10) gene
promoter. The folded line represents the intron II of the rabbit
β-globin gene. dnRARα cDNA lacks AF-2, but retains functional
domains as indicated. AF1, activation function-1; DNA, DNA-binding
domain; Ligand, tRA-binding domain; Dimer, dimerization domain.
SV40 Poly(A)n, a polyadenylation signal sequence derived from
SV40. The size of each DNA fragment is shown below the
corresponding segment. Restriction sites, NotI (N), BglII (B) and
EcoRI (E), are labeled immediately below the constructs.
(B) Photograph of newborn normal and transgenic littermates. Left: a
picture of transgenic founder 4489 (dnRARα) with a normal non-
transgenic littermate (CTRL). Right: a picture of the most severely
affected transgenic founder with a normal non-transgenic littermate.
(C) Southern blotting analysis of tail genomic DNA from the F1 mice
from transgenic lines, 4512, 4487, 4522, 4511, 4518 and 4489, and a
non-transgenic control mouse (CTRL). DNA (5 μg) was digested by
BglII. DNA fragments corresponding to the endogenous RARα gene
or the dnRARα transgene are indicated on both sides of the blot. The
estimated dnRARα transgene numbers in the mouse genome are
shown immediately below the blot. (D) Northern blot analysis of
epidermal total RNA (20 μg) from a control mouse and F1 mice from
transgenic lines, 4487, 4522, 4518 and 4489. mRNA signals
corresponding to the endogenous RARα gene or dnRARα transgene
are indicated. mRNA ratios between dnRARα and endogenous RARα
are indicated immediately below the blot. The control signals (β-actin)
show integrity and variation in the amounts of RNA samples loaded.
(E) Northern blotting analysis of total RNA from different tissues of a
dnRARα mouse (line 4489). Upper panel: autoradiography of a
Northern blot containing total RNA (20 μg) from epidermis (E),
tongue (T), lung (Lu), heart (H), liver (L) and kidney (K). Lower
panel: photograph of the ethidium bromide-stained agarose gel before
blotting, which serves as an RNA quality control.
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Fig. 2. dnRARα expressed in transgenic epidermis dose-dependently impaired induction of epidermal thickness and basal cell proliferation by tRA.
Skin of adult mice was treated with vehicle (VEH, acetone) or 8 nmol of tRA (in acetone) for 4 days with one topical application per day, and
punch biopsies (2 mm) of dorsal skin were taken for histological analysis. n refers to the number of mice analyzed. E, epidermis; D, dermis.
(A) Representative micrographs of skin sections showing lack of epidermal expansion, spongiosis and cellular volume enlargement in dnRARα mice
(line 4489) treated with tRA, in comparison with normal control littermates (CTRL) under the same treatment. Dorsal skin sections (5 μm) were
stained with hematoxylin–eosin. Bar, 25 μm. (B) Quantitation of the dnRARα effect on tRA induction of epidermal thickening in transgenic mice
from independent lines, 4522, 4518 and 4489 that express different levels of dnRARα (452245184489). The y-axis shows epidermal thickness.
Data are mean  SE. *p 0.05 versus tRA-treated control mice, as determined by Dunnett’s t test. (C) Representative micrographs of skin sections
labeled with BrdU, which show lack of proliferating basal keratinocytes in the dnRARα mice (line 4489) treated with tRA. The sections were
stained with peroxidase-conjugated antibodies against BrdU. Cells with red staining are proliferating basal keratinocytes, which were revealed by the
antibody staining. Bar, 50 μm. (D) Quantitation of levels of BrdU-incorporated basal keratinocytes in transgenic mice from independent lines 4522,
4518 and 4489 that express different levels of dnRARα (452245184489) and control non-transgenic littermates (CTRL). The y-axis represents
relative levels of BrdU-labeled basal cells expressed as a percentage of total basal cells. Data are mean  SE. *p 0.05 versus tRA-treated control
mice.
(Raab and Klagsbrun, 1997; Stoll et al., 1997). In normal
skin, keratinocytes express very low levels of these factors.
Overexpressing or treating skin with these factors causes
epidermal hyperproliferation (Vassar and Fuchs, 1991;
Dominey et al., 1993; Stoll et al., 1997). To determine
whether genes encoding EGFR and its ligands are regulated
by retinoids, we analyzed their mRNA levels in normal
mouse epidermis treated with vehicle or tRA. Figure 5A
shows that tRA did not significantly alter expression of
EGFR mRNA and protein. EGF mRNA was not detectable
by Northern blotting analysis although it was detected by
RT–PCR analysis. However, tRA did not increase the
levels of EGF mRNA (data not shown). No significant
induction of TGFα by tRA was observed (Figure 5B
and C). Interestingly, HB-EGF mRNA was induced rapidly
by tRA, reaching a maximal level ~6 h after tRA applica-
tion (Figure 5B and C). Its induction profile is similar to
that of CRABPII. We also found that amphiregulin mRNA
was not significantly altered by tRA in normal mouse
epidermis (Figure 5C). These data indicate that tRA is
able to induce selectively one member of the EGF family,
HB-EGF.
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dnRARα significantly impaired tRA induction of
HB-EGF in differentiated suprabasal cells of
transgenic epidermis
To determine whether reduction in epidermal responses
to tRA in transgenic mice is associated with dnRARα
inhibitory activity over HB-EGF, we compared HB-EGF
mRNA levels between normal and transgenic epidermis.
Figure 6 shows that the ability of tRA to induce HB-EGF
mRNA was significantly impaired in the transgenic mice.
The degree of this impairment correlated well with the
relative levels of dnRARα expressed in these transgenic
mouse lines. A similar impairment in retinoid induction
of HB-EGF mRNA was observed with K10–dnRXRα
transgenic mice (data not shown).
As dnRARα was targeted to suprabasal keratinocytes,
it raised the question as to whether the affected retinoid
regulation of HB-EGF occurs directly within suprabasal
cells or indirectly in basal cells. We analyzed expression
of HB-EGF mRNA in normal and transgenic skin by in situ
hybridization. At 8 h after tRA application, significant
induction of HB-EGF was observed exclusively in epi-
dermal suprabasal keratinocytes of normal skin
Intercellular regulation of cell growth by retinoids
Fig. 3. dnRARα in nuclear extracts of transgenic mouse epidermis
competitively formed heterodimers with endogenous RXRα over
RARE. Gel mobility supershift analysis was performed with
6 μg of nuclear extracts from epidermis of normal control mice
(CTRL) or transgenic mice (dnRARα, line 4489). 32P-labeled
oligodeoxyribonucleotide duplexes containing a RARE (DR5) from the
human RARβ2 gene promoter (de The et al., 1990) were used as
probes. Antibodies (1.5 μl) against all three members of the RXR
family (RXR-Ab), RXRα, RARγ or RARα, were added during post-
incubation as shown immediately above the gels. The types of receptor
dimeric complexes identified by antibody supershifting are labeled
along the gels.
(Figure 7A). Epidermal basal cells and dermal fibroblasts
did not show detectable levels of HB-EGF mRNA. In
transgenic skin, tRA induction of HB-EGF mRNA expres-
sion in suprabasal cells was severely impaired. Sustained
induction of HB-EGF mRNA was observed in differenti-
ated suprabasal keratinocytes of normal but not transgenic
epidermis treated with tRA for 4 days (Figure 7B). Note
that epidermal hyperplasia was observed only in control
mice treated with tRA for 4 days. Again, no specific HB-
EGF mRNA signal was observed in basal keratinocytes
and dermal fibroblasts
Discussion
Involvement of RAR–RXR or RXR–RXR dimers in the
anti-proliferative effects of retinoids has been suggested
by studies of cell lines mutated in the receptor genes or
overexpressing wild-type or mutated receptors (Frangioni
et al., 1994; Clifford et al., 1996; Chiba et al., 1997;
Isogai et al., 1997; Wan et al., 1998). On the other hand,
studies of mouse models, in which genes encoding retinoid
receptors or their coactivators are inactivated, have indi-
cated their importance in normal cell growth in organo-
genesis during embryo development (Kastner et al., 1995;
Yao et al., 1998). However, little is known about the
molecular cascades linking retinoid receptors to cell
growth and especially how retinoids stimulate cell growth.
Results from this study suggest for the first time that
in vivo regulation of basal cell growth by retinoids in
epidermis involves retinoid receptor-mediated induction
of a paracrine/juxtacrine growth factor gene, HB-EGF,
within differentiated suprabasal cells.
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Fig. 4. dnRARα dose-dependently inhibited tRA induction of the
CRABPII mRNA levels in transgenic mouse epidermis. Skin of adult
mice was treated with vehicle (VEH, acetone) or 40 nmol of tRA (in
acetone) for 20 h. Epidermal mRNA was analyzed by Northern blot
using mouse CRABPII cDNA as a probe. Top: Northern blot
containing epidermal total mRNA (20 μg) from normal control
(CTRL) or transgenic mice (line 4489). Bottom: quantitation of
CRABPII mRNA levels in the normal control and transgenic mice
from lines 4518 and 4489 that express different dnRARα levels
(45184489). The CRABPII mRNA levels are expressed as a
percentage of its basal levels in the vehicle-treated normal control
mice, after being normalized against the control β-actin signal in the
same sample. Data are mean  SE. *p 0.05 versus control mice
under the same treatment.
Role of suprabasal RARs in mediating retinoid
induction of basal cell growth in epidermis
In skin, keratinocytes constitute ~95% of the epidermal cell
population. Basal keratinocytes are located immediately
above the basement membrane that separates the epidermal
and dermal compartments. These undifferentiated cells
possess the potential to proliferate to give daughter cells,
which lose contact with the basement membrane and the
ability to proliferate while moving up to suprabasal layers
and undergoing differentiation. In adult mouse skin, ~2%
of basal cells are proliferating at any given time (Figure 2D;
Feng et al., 1997). Retinoids applied externally to skin
increase the number of basal cells entering into the
proliferative phase. In epidermis of K10–dnRARα mice,
the stimulatory effect of tRA on basal cell growth was
impaired dose-dependently by dnRARα targeted to supra-
basal cells (Figure 2). This phenomenon indicates that the
activity of endogenous suprabasal RARs is required for
basal cells to respond to retinoids. Disruption of such
activity by dnRARα impairs the ability of retinoids to
induce growth signaling from suprabasal cells to basal
cells, resulting in a lack of epidermal hyperplasia in K10–
dnRARα mice. Saitou et al. (1995) have targeted a
dnRARα to basal cells using the keratin-14 gene promoter.
They observed that disruption of retinoid signaling by
dnRARα in basal cells inhibited fetal skin development.
The skin of affected K14–dnRARα animals had neither
J.-H.Xiao et al.
Fig. 5. tRA rapidly and selectively induced mRNA levels of one member of the EGF family, HB-EGF, in normal mouse epidermis. Skin of adult
mice was treated with vehicle (VEH, acetone) or 40 nmol of tRA (in acetone). (A) Epidermis of normal mice was treated with for 20 h and
subjected to the following analyses. Left: Northern blot analysis of EGFR mRNA. Right: Western blot analysis of EGFR protein. The positions of
pre-stained molecular weight markers for proteins (Bio-Rad Laboratories, Hercules, CA) are indicated to the left of the Western blot. The same blots
were probed for β-actin, which was used as a control for the integrity of mRNA and proteins and loading variation. Each lane represents one
individual mouse that received the treatment indicated. (B) Northern blot analysis of CRABPII, HB-EGF and TGF-α expression in normal mouse
epidermis treated with tRA. Epidermal biopsies were taken at the indicated times (h) after the tRA application. (C) The time course of tRA
induction of CRABPII, HB-EGF, TGF-α and amphiregulin (AR) mRNA in epidermis of normal mice. The y-axis represents relative mRNA levels
expressed as fold induction over basal levels in vehicle-treated mice. The x-axis shows time of sampling after tRA application. Data are
mean  SE (n 5) and were normalized against the β-actin mRNA signal. *p 0.05 versus the vehicle-treated mice.
wrinkles nor hairs, was very thin (30–70% of normal
skin thickness) and dried rapidly. The animals died within
a few hours after birth. These phenotypes were not
observed in the K10–dnRARα mice, suggesting that basal
cell RARs play an important role during skin development
whereas suprabasal RARs mediate the epidermal hyperpro-
liferative response to retinoids in adult skin. Together with
the fact that suprabasal expression of dnRXRα blocked
the hyperproliferative response of basal cells to retinoids
(Feng et al., 1997), our observations strongly support the
idea that suprabasal RAR–RXR is the functional unit
mediating retinoid signaling in intercellular regulation of
basal cell growth.
Impairment of RARγ –RXRα heterodimer-mediated
gene transactivation by dnRARα in transgenic
mouse epidermis
In vitro analysis has shown that dnRARα lacking its AF-2
is capable of binding RAREs as heterodimers with RXRs
(Damm et al., 1993; Durand et al., 1994). However, such
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dimers do not transactivate in the presence of retinoids,
due to their inability to interact with co-activators. In
addition, their interaction with retinoids fails to release
co-repressors, in contrast to wild-type dimers (Chen and
Evans, 1995). Thus, dnRARα inhibits retinoid-dependent
gene transactivation mediated by wild-type RAR–RXR
through competing with wild-type RARs for RXR partners
and binding to RAREs. Consistent with its properties
in vitro, this study shows that dnRARα in transgenic
epidermis formed dnRARα–RXRα heterodimers in com-
petition with RARγ (Figure 3). The functional impact of
dnRARα on gene transactivation was demonstrated by its
ability to inhibit transactivation of the CRABPII gene by
endogenous retinoid receptors (Figure 4). Gel supershifts
showed that RARγ–RXRα is the predominant receptor
form interacting with RAREs in normal epidermis
(Figure 3), consistent with previous findings (Xiao et al.,
1995; Feng et al., 1997). Although low levels of endogen-
ous RARα mRNA were present in the epidermis
(Figure 1D), endogenous RARα–RXRα heterodimers
Intercellular regulation of cell growth by retinoids
Fig. 6. dnRARα dose-dependently inhibited tRA induction of the
HB-EGF mRNA levels in transgenic epidermis. Northern blot analysis
of HB-EGF expression was performed with the same samples in
Figure 4 using HB-EGF cDNA as a probe. The HB-EGF mRNA
levels are expressed as a percentage of its basal levels in the vehicle-
treated normal control mice, after being normalized against the β-actin
signal. Data are mean  SE. *p 0.05 versus tRA-treated control
mice.
were not detected (Figure 3). Therefore, RARγ–RXRα
most likely dominates regulation of RARE-containing
genes such as CRABPII, consistent with previous findings
(Feng et al., 1997). However, we cannot exclude the
possibility that the minute amount of endogenous RARα–
RXRα contributes in part to tRA effects in epidermis.
In K10–dnRARα mice, the basal level of CRABPII
transcription in epidermis was found to be lower than that
in the normal control mice (Figure 4). This reduction is
probably caused by the mutation-increased ability of
dnRARα–RXRα to interact with nuclear receptor co-
repressors (Chen and Evans, 1995). Such a reduction,
however, was not observed in K10–dnRXRα mice (Feng
et al., 1997). One possible explanation for this difference
between the two types of mice is that in untreated dnRXRα
mouse epidermis, co-repressors were bound less tightly
to RARγ–dnRXRα than to dnRARα–RXRα in untreated
dnRARα mouse epidermis. Unlike the CRABPII gene,
basal transcription of the HB-EGF gene was not signific-
antly affected by dnRARα. This finding raises the possi-
bility that repression of basal transcription by dnRARα–
RXRα may be gene specific, depending on whether
retinoid receptors are involved directly or indirectly in
regulation of HB-EGF transcription (see Discussion
below).
Cell-specific expression and regulation of HB-EGF
by RAR–RXR heterodimers in vivo
The expression pattern of HB-EGF transcripts in skin
in vivo (Figure 7) is similar to that of the endogenous
K-10 gene (data not shown), specific to differentiated
suprabasal keratinocytes. No expression of HB-EGF in
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dermal fibroblasts and basal keratinocytes was detected
by in situ hybridization (Figure 7), indicating that its gene
is silent in these cells. Its transcription is most likely
regulated by suprabasal-specific transcription factors.
Keratinocytes cultured in vitro are considered to be similar
to basal keratinocytes based on their ability to proliferate
and express basal cell-specific genes such as keratin-5
and -14. In these cultured cells, basal expression and
autocrine regulation of HB-EGF have been observed
(Hashimoto et al., 1994). This difference between in vitro
and in vivo observations suggests that HB-EGF is subject
to different regulation mechanisms in basal keratinocytes
in skin in vivo versus keratinocytes cultured in vitro.
As shown by Northern analysis, tRA induced HB-EGF
but not other members of the EGF family in normal
epidermis (Figure 5). The time course profile of the
induction mirrors that of the RARE-containing gene,
CRABPII (Figure 5). In transgenic mice, this induction
was impaired by dnRARα or dnRXRα targeted to the
suprabasal cells (Figures 6 and 7; and data not shown).
Together, these observations strongly suggest that RARs
in the form of RAR–RXR heterodimers play a key role
in regulation of the HB-EGF gene. Examination of the
published sequence of the HB-EGF gene promoter (Chen
et al., 1995) failed to reveal any putative RAREs. It is
possible that this gene contains as yet unidentified RAREs
upstream or downstream of the previously reported pro-
moter region. Alternatively, the HB-EGF gene may be
regulated by a retinoid-responsive transcription factor(s)
that binds to its transcriptional regulatory regions. Further
analysis of the HB-EGF gene sequence and characteriz-
ation of its transcriptional regulatory regions will be
required to distinguish among these possibilities.
Role of retinoid receptor-regulated HB-EGF in
intercellular regulation of basal cell growth by
retinoids
Unlike in vitro cell culture systems, in adult animal tissues
in vivo, stem or undifferentiated cells undergo cell division
at a low rate to give daughter cells, and simultaneously
regenerate themselves. These cells co-exist and communic-
ate constantly with differentiating daughter cells. This
study revealed for the first time that retinoids are able
selectively to regulate one member of the EGF family, HB-
EGF, within the differentiated cell compartment (Figure 7).
HB-EGF is a heparin-binding member of the EGF super-
family. In many cell types including keratinocytes, HB-
EGF signals through EGFR to induce cell proliferation and
motility by paracrine, juxtacrine or autocrine mechanisms
(Raab and Klagsbrun, 1997). In normal skin, mature HB-
EGF proteins have been localized to epidermal basal cells
(Downing et al., 1997). However, our study revealed that
low basal levels of HB-EGF mRNA are present only in
suprabasal but not basal keratinocytes nor dermal
fibroblasts in normal skin (Figure 7). This location differ-
ence suggests that HB-EGF is produced by suprabasal
cells and translocates to interact with EGFR on the basal
cell surface (King et al., 1990; Vassar and Fuchs, 1991)
to maintain normal cell growth. The HB-EGF induction
occurs within differentiated suprabasal keratinocytes
(Figure 7A) prior to the onset of basal keratinocyte
hyperproliferation (Figures 2 and 7B). The dose-dependent
inhibitory effects of dnRARα on tRA induction of
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Fig. 7. Expression of dnRARα in transgenic mouse epidermis impaired retinoid induction of HB-EGF mRNA by tRA exclusively within
differentiated suprabasal cells. In situ hybridization analysis of HB-EGF expression was performed with skin sections from normal control (CTRL)
and transgenic mice (dnRARα, line 4489) using digoxigenin-labeled HB-EGF riboprobes. Alkaline phosphatase-conjugated antibodies specific to
digoxigenin were used to reveal hybridization signals. HB-EGF mRNA is stained dark purple. Dorsal skin was treated with vehicle (acetone, VEH)
or 20 nmol of tRA for 8 h (A) or 4 days (B) before the analysis. Bar, 50 μm. AS refers to skin sections (upper micrographs) subjected to
hybridization using the antisense probe. S refers to skin sections (lower micrographs) analyzed with the sense probe, which serves as a control for
background signals.
HB-EGF correlated well with its inhibitory effects on the
tRA induction of basal cell proliferation. Our data suggest
that retinoids induce HB-EGF expression via RAR–RXR
in differentiated suprabasal cells, and the resultant high
levels of HB-EGF cause basal keratinocyte hyperprolifer-
ation, most probably through paracrine or juxtacrine mech-
anisms (Figure 8), and consequently epidermal
hyperplasia. Induction of HB-EGF by tRA in vivo is
unlikely to trigger its autoregulation observed in cultured
keratinocytes (Hashimoto et al., 1994) because its gene is
silent in basal keratinocytes in epidermis and because
differentiated suprabasal cells, in which the HB-EGF gene
is active, do not have EGFR to respond to its autocrine
signaling. Consistent with this idea, no induction of HB-
EGF in basal keratinocytes nor suprabasal cell proliferation
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was observed in skin treated with tRA for 4 days (Figures
2C and 7B).
Potential roles of retinoid receptor-regulated
HB-EGF in the retinoid effects on epidermal
regeneration during wound healing
A previous study has shown that in skin wound sites
where basal cell proliferation is increased, levels of HB-
EGF proteins were found to be elevated in differentiated
suprabasal keratinocytes (McCarthy et al., 1996). On the
other hand, it has been known for over half a century
that vitamin A deficiency causes delayed wound healing
(Brandaleone and Papper, 1941; Hunt, 1970). Pre-
treatment with vitamin A and tRA was reported to improve
skin wound healing in animals and humans (Strigini and
Intercellular regulation of cell growth by retinoids
Fig. 8. A proposed in vivo model for regulation of cell proliferation in
the undifferentiated cell compartment by retinoids acting on the
differentiated cell compartment in epidermis.
Ryan, 1996 and references therein). As retinoid induction
of HB-EGF occurs prior to the onset of basal cell hyper-
proliferation, and both can be inhibited by dnRARα
(Figure 7), it raises the possibility that HB-EGF may be
implicated in retinoid actions in epidermal regeneration
during wound healing. In this regard, the dnRARα mouse
model will be a useful tool to study further the role of
retinoids and their receptors in wound healing responses.
Under normal vitamin A status, adult dnRARα mice
appear to have normal epidermal structure and cellularity.
Presumably, basal levels of HB-EGF and other retinoid-
insensitive growth factors (Figure 5) are sufficient to
maintain epidermal thickness and functions that require
only a low rate of cell proliferation in these transgenic
mice in the laboratory environment. Alternatively, the
unaffected retinoid signaling pathway in basal keratino-
cytes may be sufficient to support a low rate of homeostatic
growth required for maintaining a normal epidermis.
Targeted mutation or overexpression of the HB-EGF gene
in suprabasal keratinocytes will be required to ascertain
whether HB-EGF is the only major mediator in spatial
regulation of epidermal growth by retinoid receptors. Our
finding evokes the possibility that spatial regulation of
HB-EGF-mediated cell growth by retinoid receptors may
occur in other tissues during embryo development and/or
in adulthood.
The side effect, skin peeling, observed during
retinoid therapy of skin disorders may not be
eliminated by designing synthetic RAR-selective
agonists
Retinoids such as tRA are used widely in the clinical
therapy of skin disorders such as acne vulgaris, psoriasis
and photoaging (Craven and Griffiths, 1996). One of the
major side effects caused by retinoids is skin peeling/
flaking, due to an accelerated shedding of epidermal cells.
Our findings suggest that this event is initiated by early
induction of suprabasal HB-EGF followed by basal cell
hyperproliferation. This ultimately causes a faster epi-
dermal cell turnover, resulting in epidermal cell shedding/
skin peeling. As retinoid induction of HB-EGF is mediated
by RARs, design of new synthetic retinoids selective for
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RARs may not eliminate this side effect since the receptors
that mediate the side effects are probably the same as
those mediating the therapeutic effects of retinoids.
Materials and methods
Construction of transgene K10–dnRARα
To construct K10–dnRARα, a 1.5 kb EcoRI–BamHI fragment from
pSG5-mRARαT403 (Durand et al., 1994), which contains dnRXRα
cDNA, was inserted into polycloning sites in pXJ81L between EcoRI
and BamHI sites, resulting in pXJ81L-mRARαT403.
Preparation of transgenic mice
K10–dnRARα (7.2 kb) was liberated from plasmid vectors pXJ81L-
mRARαT403 by digestion with NotI, separated by electrophoresis on a
0.8% agarose gel, and purified through a Nucleobond AX20 column
(The Nest Group). The purified DNA fragment was microinjected
into F2 hybrid zygotes from C57BL/6JSJL/J parents (the Jackson
Laboratory) at a concentration of 2–3 ng/μl as previously described
(Feng et al., 1997). After overnight incubation, the eggs which survived
to the two-cell stage were transferred to day 0.5 post-coitum pseudo-
pregnant CD-1 females (Charles River). Founder transgenic mice were
mated to C57BL/6J mice to give F1 offspring. F2–4 offspring were
produced by crossing F1–F3 transgenic mice with C57BL/6J mice. The
microinjection was carried out by the Transgenic Animal Model Core
in the University of Michigan’s Biomedical Research Core Facilities.
Adult mice were fed with laboratory rodent diet #5001 (PMI Feeds
Inc.). All procedures involving mice were approved by the University
of Michigan Committee on Use and Care of Animals, and were conducted
in accord with the principles outlined in the NIH Guidelines for the
Care and Use of Experimental Animals.
Preparation of cDNA probes
Mouse CRABPII and β-actin cDNA probes were described previously.
To prepare mouse EGFR (DDBJ/EMBL/GenBank accession No. X78987,
positions 60–380), TGF-α (DDBJ/EMBL/GenBank accession No.
M92420, positions 6–485), HB-EGF (DDBJ/EMBL/GenBank accession
No. L07264, positions 226–570) and amphiregulin (DDBJ/EMBL/
GenBank accession No. L41352, positions 76–520) cDNA, mouse
epidermal RNA was reverse-transcribed and amplified using an RT–
PCR kit (Stratagene) and a pair of corresponding primers of 30 bp.
The resulting DNA fragments were subcloned into the PCRII vector
(Invitrogen) and verified by sequencing. For Northern blotting, cDNA
probes were labeled with [α-32P]dCTP (3000 Ci/mmol) (DuPont-NEN)
using a random priming kit (Life Technologies). For in situ hybridization
experiments, cDNA containing the entire coding region of mouse HB-
EGF (DDBJ/EMBL/GenBank accession No. L07264, positions 211–
860) was cloned by RT–PCR.
PCR genotyping, Northern and Southern blotting, gel
mobility supershift and histological analyses
These analyses were performed as described previously (Feng et al.,
1997).
Western blotting analysis of EGFR protein in mouse
epidermis
After topical retinoid treatment, epidermal biopsies were taken as
described previously (Feng et al., 1997) and immediately frozen in liquid
nitrogen. Epidermal whole cell extracts were prepared and analyzed by
Western blotting according to Fisher et al. (1998). EGFR was analyzed
using a rabbit IgG specific to its C-terminus (Santa Cruz Biotechnology
Inc., Santa Cruz, CA) and visualized using the ECL system (Amersham
Life Science Inc., Arlington Heights, IL). A retinoid-insensitive control
protein, β-actin, was measured subsequently using a mouse monoclonal
antibody specific to its N-terminus (Sigma).
In situ hybridization analysis
To prepare sense and antisense probes, the PCRII vector containing the
full-length HB-EGF cDNA was linearized by digestion with HindIII or
NotI, respectively. Digoxigenin-UTP-labeled sense and antisense RNA
probes were prepared from these templates using T7 or Sp6 RNA
polymerases, respectively, and the DIG RNA labeling kit (Boehringer
Mannheim). Punch biopsies (2 mm) were taken from mouse dorsal skin
and embedded in an OCT compound, Tissue-Tek (Miles Laboratories).
Frozen sections (7 μm) were prepared from the specimens using a
J.-H.Xiao et al.
cryostat and subjected to an in situ hybridization process as previously
described (Kang et al., 1995). RNA hybridization signals were revealed
by staining with alkaline phosphatase-conjugated anti-digoxigenin anti-
bodies.
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